3 results
Primary objective- Survival without BPD at 36 weeks gestational age (GA)Secondary objectives- Neurodevelopment at a corrected age of 18-22 months- Adverse treatment effects- Mortality at 36 weeks gestational age- BPD incidence at 36 weeks…
To gain clinical experience for the Ellipse IM HTO Nail System in subjects with osteoarthritis and varus malalignment of the knee:1. To further evaluate the safety profile of the Ellipse IM HTO Nail System2. To further evaluate the efficacy of the…
Lu AF28996 is an orally administered investigational compound of a potent, long-acting dopamine agonist, Lu AA40326, currently under development by H. Lundbeck A/S for the treatment of Parkinson*s disease (PD). Primary Objective:to investigate the…